LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.

NCT05682482 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Hypothyroidism

Interventions

DRUG: LT3 (liothyronine)
DRUG: Placebo

Sponsor

M. Medici

Collaborators

[object Object]
[object Object]